Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors

This chapter reviews papers mostly written since 2005 that report results using live attenuated bacterial vectors to deliver after administration through mucosal surfaces, protective antigens, and DNA vaccines, encoding protective antigens to induce immune responses and/or protective immunity to pat...

Descripción completa

Detalles Bibliográficos
Autor principal: Curtiss, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148735/
http://dx.doi.org/10.1016/B978-0-12-415847-4.00064-1
_version_ 1783520656724328448
author Curtiss, Roy
author_facet Curtiss, Roy
author_sort Curtiss, Roy
collection PubMed
description This chapter reviews papers mostly written since 2005 that report results using live attenuated bacterial vectors to deliver after administration through mucosal surfaces, protective antigens, and DNA vaccines, encoding protective antigens to induce immune responses and/or protective immunity to pathogens that colonize on or invade through mucosal surfaces. Papers that report use of such vaccine vector systems for parenteral vaccination or to deal with nonmucosal pathogens or do not address induction of mucosal antibody and/or cellular immune responses are not reviewed.
format Online
Article
Text
id pubmed-7148735
institution National Center for Biotechnology Information
language English
publishDate 2015
record_format MEDLINE/PubMed
spelling pubmed-71487352020-04-13 Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors Curtiss, Roy Mucosal Immunology Article This chapter reviews papers mostly written since 2005 that report results using live attenuated bacterial vectors to deliver after administration through mucosal surfaces, protective antigens, and DNA vaccines, encoding protective antigens to induce immune responses and/or protective immunity to pathogens that colonize on or invade through mucosal surfaces. Papers that report use of such vaccine vector systems for parenteral vaccination or to deal with nonmucosal pathogens or do not address induction of mucosal antibody and/or cellular immune responses are not reviewed. 2015 2015-03-13 /pmc/articles/PMC7148735/ http://dx.doi.org/10.1016/B978-0-12-415847-4.00064-1 Text en Copyright © 2015 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Curtiss, Roy
Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
title Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
title_full Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
title_fullStr Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
title_full_unstemmed Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
title_short Antigen Delivery System II: Development of Live Attenuated Bacterial Vectors
title_sort antigen delivery system ii: development of live attenuated bacterial vectors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7148735/
http://dx.doi.org/10.1016/B978-0-12-415847-4.00064-1
work_keys_str_mv AT curtissroy antigendeliverysystemiidevelopmentofliveattenuatedbacterialvectors

Ejemplares similares